Publications 2018-2020

Publications of the LBI for Cardiovascular Research 2020

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered publications of the institute.

Publications ASC:

  • Aigner P, Schweiger M, Fraser K, Choi Y, Lemme F, Cesarovic N, Kertzscher U, Schima H, Hübler M,
  • Grabska J, Schlöglhofer T, Gross C, Maw M, Dimitrov K, Wiedemann D, Zimpfer D, Schima H, Moscato F. Early detection of pump Tthrombosis in patients with left ventricular assist device. ASAIO J. 2020;66:348-354.
  • Granegger M. Ventricular flow field visualization during mechanical circulatory support in the assisted isolated beating heart. Ann Biomed Eng. 2020;48:794-804.
  • Gross C, Fresiello L, Schlöglhofer T, Dimitrov K, Marko C, Maw M, Meyns B, Wiedemann D, Zimpfer D, Schima H, Moscato F. Hemodynamic exercise responses with a continuous-flow left ventricular assist device: Comparison of patients’ response and cardiorespiratory simulations. PLoS One. 2020;15:e0229688.
  • Gross C, Moscato F, Schlöglhofer T, Maw M, Meyns B, Marko C, Wiedemann D, Zimpfer D, Schima H, Fresiello L. LVAD speed increase during exercise, which patients would benefit the most? A simulation study. Artif Organs. 2020;44:239-247.
  • Gross C, Schima H, Schlöglhofer T, Dimitrov K, Maw M, Riebandt J, Wiedemann D, Zimpfer D, Moscato F. Continuous LVAD monitoring reveals high suction rates in clinically stable outpatients. Artif Organs. 2020;44:E251-E262.
  • Kertzscher U, Lommel M, Gabel G, Ładyżyński P, Schima H. In Memoriam: Klaus Affeld. Int J Artif Organs. 2020;43:292-293.
  • Stoiber M, Grasl C, Frieberger K, Moscato F, Bergmeister H, Schima H. Impact of the testing protocol on the mechanical characterization of small diameter electrospun vascular grafts. J Mech Behav Biomed Mater. 2020;104:103652.
  • Stoiber M, Aigner P, Grasl C, Röhrich M, Moscato F, Schima H. Dynamic measurement of centering forces on transvalvular cannulas. Artif Organs. 2020;44:E150-E160.

Publications INFO:

  • Demyanets S, Kaun C, Kaider A, Speidl W, Prager M, Oravec S, Hohensinner P, Wojta J, Rega-Kaun G. The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery. Cardiovasc Diabetol. 2020;19:26.
  • Hammer A, Sulzgruber P, Koller L, Kazem N, Hofer F, Richter B, Blum S, Hülsmann M, Wojta J, Niessner A. The prognostic impact of crculating regulatory T lymphocytes on mortality in patients with ischemic heart failure with reduced ejection fraction. Mediators Inflamm. 2020;2020:6079713.
  • Kastl SP, Katsaros KM, Krychtiuk KA, Jägersberger G, Kaun C, Huber K, Wojta J, Speidl WS. The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro. PLoS One. 2020;15:e0232483.
  • Lenz M, Draxler DF, Zhang C, Kassem M, Kastl SP, Niessner A, Huber K, Wojta  J, Heinz G, Speidl WS, Krychtiuk KA. Toll-like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients. Shock. 2020;54:35-43.
  • Rega-Kaun G, Kaun C, Jaegersberger G, Prager M, Hackl M, Demyanets S, Wojta J, Hohensinner PJ. Roux-en-Y-bariatric surgery reduces markers of metabolic syndrome in morbidly obese patients. Obes Surg. 2020;30:391-400.
  • Stojkovic S, Koller L, Sulzgruber P, Hülsmann M, Huber K, Mayr M, Hengstenberg C, Wojta J, Niessner A. Liver-specific microRNA-122 as prognostic biomarker in patients with chronic systolic heart failure. Int J Cardiol. 2020;303:80-85.
  • Wojta J. Macrophages and Thrombin-Another Link between Inflammation and Coagulation. Thromb Haemost. 2020;120:537.

REM:

  • Kiss A, Heber S, Kramer AM, Hackl M, Skalicky S, Hallström S, Podesser BK, Santer D. MicroRNA Expression profile changes after cardiopulmonary bypass and ischemia/reperfusion-injury in a porcine model of cardioplegic arrest. Diagnostics. 2020;10:240.
  • Pilz PM, Lang M, Hamza O, Szabo PL, Inci M, Kramer AM, Koch M, Huber J, Podesser BK, Kiss A. Semi-minimal invasive method to induce myocardial infarction in rats and the assessment of cardiac function by an isolated working heart system. J Vis Exp. 2020;(160).
  • Podesser BK, De Paulis R. Implantability of a novel, pre-assembled aortic valved conduit with RESILIA™ tissue. J Cardiovasc Surg. 2020;61:376-379.

BIO:

  • Gremmel T, Huber K. Antithrombotic treatment strategies after PCI. Lancet. 2020;395:865.
  • Haller PM, Vargas KG, Haller MC, Piackova E, Wojta J, Gyöngyösi M, Gersh BJ, Kiss A, Podesser BK, Huber K. Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomized trials. Eur Heart J Acute Cardiovasc Care. 2020;9(1_suppl):82-92.
  • Hassager C, Price S, Huber K. Cardiac arrest in the COVID-19 era. Eur Heart J Acute Cardiovasc Care. 2020;9:239-240.
  • Huber K, Goldstein P. Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2020;9:222-228.
  • Huber K, Ulmer H, Lang IM, Mühlberger V. Coronary interventions in Austria, Germany, and Switzerland. Eur Heart J. 2020;41:2599-2600.
  • Jäger B, Haller PM, Piackova E, Kaff A, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Maurer G, Huber K; Vienna STEMI Registry Group. Predictors of transportation delay in patients with suspected ST-elevation- myocardial infarction in the VIENNA-STEMI network. Clin Res Cardiol. 2020;109:393-399.
  • Kaufmann CC, Wessely E, Huber K. Non-bacterial thrombotic endocarditis in the context of pulmonary adenocarcinoma: a case report. Eur Heart J Case Rep. 2020;4:1-5.
  • Stanetic BM, Ostojic M, Kovacevic-Preradovic T, Kos L, Stanetić K, Nikolic A, Bojic M, Huber K. ApPropRiateness of myOcardial revascUlarization assessed by SYNTAX Scores in patients with type 2 diabetes melliTus: the PROUST study. Postepy Kardiol Interwencyjnej. 2020;16:153-161.

ECP:

  • Eilenberg M, Enayati M, Ehebruster D, Grasl C, Walter I, Messner B, Baudis S, Potzmann P, Kaun C, Podesser BK, Wojta J, Bergmeister H. Long term evaluation of nanofibrous, bioabsorbable polycarbonate urethane grafts for small diameter vessel replacement in rodents. Eur J Vasc Endovasc Surg. 2020;59:643-652.

Associated publications of the LBI for Cardiovascular Research 2020

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the instituter and are listed below.

  • Aman M, Bergmeister KD, Festin C, Sporer ME, Russold MF, Gstoettner C, Podesser BK, Gail A, Farina D, Cederna P, Aszmann OC. Experimental testing of bionic peripheral nerve and muscle interfaces: animal model considerations. Front Neurosci. 2020;13:1442.
  • Angiolillo DJ, Baber U, Sartori S, Briguori C, Dangas G, Cohen DJ, Mehta SR, Gibson CM, Chandiramani R, Huber K, Kornowski R, Weisz G, Kunadian V, Oldroyd KG, Ya-Ling H, Kaul U, Witzenbichler B, Dudek D, Sardella G, Escaned J, Sharma S, Shlofmitz RA, Collier T, Pocock S, Mehran R. Ticagrelor with or without aspirin in high-risk patients with diabetes mellitus undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2020;75:2403-2413.
  • Bauer T, Zeymer U, Diallo A, Vicaut E, Bolognese L, Cequier A, Huber K, Montalescot G, Hamm CW, Van’t Hof AW; ATLANTIC Investigators. Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study. Catheter Cardiovasc Interv. 2020;95:494-500.
  • Bergmark BA, O’Donoghue ML, Murphy SA, Kuder JF, Ezhov MV, Ceška R, Gouni-Berthold I, Jensen HK, Tokgozoglu SL, Mach F, Huber K, Gaciong Z, Lewis BS, Schiele F, Jukema JW, Pedersen TR, Giugliano RP, Sabatine MS. An exploratory analysis of proprotein convertase subtilisin/kexin type 9 inhibition and aortic stenosis in the FOURIER trial. JAMA Cardiol. 2020;5:1–6.
  • Biesinger BS, Gasecka A, Perkmann T, Wojta J, Lesiak M, Grygier M, Eyileten C, Postuła M, Filipiak KJ, Toma A, Hengstenberg C, Siller-Matula JM. Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS. Platelets. 2020;5:1-9.
  • Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Mauri Ferré J, Windecker S, Dudek D, Baumbach A. EAPCI Position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic. Eur Heart J. 2020;41:1839-1851.
  • Dangas G, Baber U, Sharma S, Giustino G, Mehta S, Cohen DJ, Angiolillo DJ, Sartori S, Chandiramani R, Briguori C, Dudek D, Escaned J, Huber K, Collier T, Kornowski R, Kunadian V, Kaul U, Oldroyd K, Sardella G, Shlofmitz R, Witzenbichler B, Ya-Ling H, Pocock S, Gibson CM, Mehran R. Ticagrelor with or without aspirin after complex PCI. J Am Coll Cardiol. 2020;75:2414-2424.
  • Demyanets S, Stojkovic S, Mauracher LM, Kopp CW, Wojta J, Thaler J, Panzer S, Gremmel T. Surrogate markers of neutrophil extracellular trap formation are associated with ischemic outcomes and platelet activation after peripheral angioplasty and stenting. J Clin Med. 2020;9:304.
  • Ebner J, Cagalinec M, Kubista H, Todt H, Szabo PL, Kiss A, Podesser BK, Cserne Szappanos H, Hool LC, Hilber K, Koenig X. Neuronal nitric oxide synthase regulation of calcium cycling in ventricular cardiomyocytes is independent of Cav/1.2 channel modulation under basal conditions. Pflugers Arch. 2020;472:61-74.
  • Ebner J, Uhrin P, Szabo PL, Kiss A, Podesser BK, Todt H, Hilber K, Koenig X. Reduced Na+ current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy. Am J Physiol Heart Circ Physiol. 2020;318:H1436-H1440.
  • Ehrmann K, Potzmann P, Dworak C, Bergmeister H, Eilenberg M, Grasl C, Koch T, Schima H, Liska R, Baudis S. Hard block degradable polycarbonate urethanes: promising biomaterials for electrospun vascular prostheses. Biomacromolecules. 2020;21:376-387.
  • Feistritzer HJ, Desch S, Freund A, Poess J, Zeymer U, Ouarrak T, Schneider S, de Waha-Thiele S, Fuernau G, Eitel I, Noc M, Stepinska J, Huber K, Thiele H. Prognostic impact of active mechanical circulatory support in cardiogenic shock complicating acute myocardial infarction, results from the culprit-shock trial. J Clin Med. 2020;9:E1976.
  • Freund A, Jobs A, Lurz P, Feistritzer HJ, de Waha-Thiele S, Meyer-Saraei R, Montalescot G, Huber K, Noc M, Windecker S, Zeymer U, Ouarrak T, Schneider S, Thiele H, Desch S. Frequenc and impact of bleeding on outcome in patients with cardiogenic shock. JACC Cardiovasc Interv. 2020;13:1182-1193.
  • Göschl L, Preglej T, Boucheron N, Saferding V, Müller L, Platzer A, Hirahara K, Shih HY, Backlund J, Matthias P, Niederreiter B, Hladik A, Kugler M, Gualdoni GA, Scheinecker C, Knapp S, Seiser C, Holmdahl R, Tillmann K, Plasenzotti R, Podesser B, Aletaha D, Smolen JS, Karonitsch T, Steiner G, Ellmeier W, Bonelli M. Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis. J Autoimmun. 2020;108:102379.
  • Kozieł M, Merino JL, De Caterina R, Huber K, Jin J, Melino M, Goette A, Lip GYH; ENSURE-AF Investigators. Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial. Eur J Clin Invest. 2020;50:e13221.
  • Mair J, Cullen L, Giannitsis E, Hammarsten O, Huber K, Jaffe A, Mills N, Möckel M, Müller C, Thygesen K, Lindahl B. Application of the fourth universal definition of myocardial infarction in clinical practice. Biomarkers. 2020;25:322-330.
  • Roth C, Krychtiuk KA, Gangl C, Schrutka L, Distelmaier K, Wojta J, Hengstenberg C, Berger R, Speidl WS. Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes: An observational cohort study. PLoS One. 2020;15:e0227054.
  • Rubini Giménez M, Miller PE, Alviar CL, van Diepen S, Granger CB, Montalescot G, Windecker S, Maier L, Serpytis P, Serpytis R, Oldroyd KG, Noc M, Fuernau G, Huber K, Sandri M, de Waha-Thiele S, Schneider S, Ouarrak T, Zeymer U, Desch S, Thiele H. Outcomes associated with respiratory failure for patients with cardiogenic shock and acute myocardial infarction: A substudy of the CULPRIT-SHOCK trial. J Clin Med. 2020;9:860.
  • Rubini Gimenez M, Zeymer U, Desch S, de Waha-Thiele S, Ouarrak T, Poess J, Meyer-Saraei R, Schneider S, Fuernau G, Stepinska J, Huber K, Windecker S, Montalescot G, Savonitto S, Jeger RV, Thiele H. Sex-Specific Management in patients with acute myocardial infarction and cardiogenic shock: A substudy of the CULPRIT-SHOCK trial. Circ Cardiovasc Interv. 2020;13:e008537.
  • Takahashi K, Kogame N, Tomaniak M, Chichareon P, Chang CC, Modolo R, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Buszman P, Bolognese L, Tumscitz C, Żmudka K, Aminian A, Vrolix M, Petrov I, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Onuma Y, Valgimigli M, Windecker S, Vranckx P, Garg S, Serruys PW. Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial. Clin Res Cardiol. 2020;109:918-929.
  • Tavenier AH, Hermanides RS, Fabris E, Lapostolle F, Silvain J, Ten Berg JM, Lassen JF, Bolognese L, Cantor WJ, Cequier Á, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Ecollan P, Collet JP, Willems FF, Diallo A, Vicaut E, Hamm CW, Montalescot G, van ‘t Hof AWJ; ATLANTIC investigators. Efficacy and safety of glycoprotein IIb/IIIa inhibitors on top of ticagrelor in STEMI: A subanalysis of the ATLANTIC trial. Thromb Haemost. 2020;120:65-74.
  • Wernly B, Paar V, Aigner A, Pilz PM, Podesser BK, Förster M, Jung C, Hofbauer JP, Tockner B, Wimmer M, Kraus T, Motloch LJ, Hackl M, Hoppe UC, Kiss A, Lichtenauer M. Anti-CD3 antibody treatment reduces scar formation in a rat model of myocardial infarction. Cells. 2020;9:295.
  • Wohlrab P, Boehme S, Kaun C, Wojta J, Spittler A, Saleh L, Knöfler M, Markstaller K, Klein KU, Tretter V. Ropivacaine activates multiple proapoptotic and inflammatory signaling pathways that might subsume to trigger epidural-related maternal fever. Anesth Analg. 2020;130:321-331.
  • Zeymer U, Bueno H, Granger CB, Hochman J, Huber K, Lettino M, Price S, Schiele F, Tubaro M, Vranckx P, Zahger D, Thiele H. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care. 2020;9:183-197.

Publications of the LBI for Cardiovascular Research 2019

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered be publications of the institute.

Publications ASC:

  • Granegger M, Thamsen B, Moscato F, Schlöglhofer T, Gross C, Schneider S, Röhrich M, Kertzscher U, Zimpfer D, Affeld K, Schima H. Noninvasive assessment of blood pressure in rotary blood pump recipients using a novel ultrasonic Doppler method. Int J Artif Organs. 2019;42:226-232.
  • Gross C, Marko C, Mikl J, Altenberger J, Schlöglhofer T, Schima H, Zimpfer D, Moscato F. LVAD pump flow does not adequately increase with exercise. Artif Organs. 2019;43:222-228.

Publications INFO:

  • Rega-Kaun G, Kaun C, Ebenbauer B, Jaegersberger G, Prager M, Wojta J, Hohensinner PJ. Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin. J Thromb Thrombolysis. 2019;47:51-56.
  • Rega-Kaun G, Ritzel D, Kaun C, Ebenbauer B, Thaler B, Prager M, Demyanets S, Wojta J, Hohensinner PJ. Changes of circulating extracellular vesicles from the liver after Roux-en-Y bariatric surgery. Int J Mol Sci. 2019;20:2153.
  • Sulzgruber P, Schnaubelt S, Koller L, Goliasch G, Niederdöckl J, Simon A, El-Hamid F, Rothgerber DJ, Wojta J, Niessner A. Cardiac arrest as an age-dependent prognosticator for long-term mortality after acute myocardial infarction: the potential impact of infarction size. Eur Heart J Acute Cardiovasc Care. 2019;8:153-160.
  • Thaler B, Baik N, Hohensinner PJ, Baumgartner J, Panzenböck A, Stojkovic S, Demyanets S, Huk I, Rega-Kaun G, Kaun C, Prager M, Fischer MB, Huber K, Speidl WS, Parmer RJ, Miles LA, Wojta J. Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets. Blood. 2019;134:561-567.
  • Thaler B, Hohensinner PJ, Baumgartner J, Haider P, Krychtiuk KA, Schörgenhofer C, Jilma B, Hell L, Fischer MB, Huber K, Hengstenberg C, Speidl WS, Wojta J. Protease-activated receptors 1 and 3 are differentially expressed on human monocyte subsets and are upregulated by lipopolysaccharide ex vivo and in vivo. Thromb Haemost. 2019;119:1394-1402.

Publications REM:

  • Gonçalves IF, Acar E, Costantino S, Szabo PL, Hamza O, Tretter EV, Klein KU, Trojanek S, Abraham D, Paneni F, Hallström S, Kiss A, Podesser BK. Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism. J Hypertens. 2019;37:1861-1870.
  • Hamza O, Kiss A, Kramer AM, Tillmann KE, Podesser BK. Characterization of a novel percutaneous closed chest swine model of ischemic mitral regurgitation guided by contrast echocardiography. EuroIntervention. 2019 Jun 25:EIJ-D-19-00095.
  • Kiss A, Podesser BK. Cardioprotection by PEDF: A novel form of GLUT4 membrane translocation to reduce myocardial ischemic injury. Int J Cardiol. 2019;288:119-120.
  • Nagel F, Santer D, Stojkovic S, Kaun C, Schaefer AK, Krššák M, Abraham D, Bencsik P, Ferdinandy P, Kenyeres E, Szabados T, Wojta J, Trescher K, Kiss A, Podesser BK. The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice. Exp Gerontol. 2019;119:193-202.
  • Pilz PM, Hamza O, Gidlöf O, Gonçalves IF, Tretter EV, Trojanek S, Abraham D, Heber S, Haller PM, Podesser BK, Kiss A. Remote ischemic perconditioning attenuates adverse cardiac remodeling and preserves left ventricular function in a rat model of reperfused myocardial infarction. Int J Cardiol. 2019;285:72-79.
  • Santer D, Kramer A, Kiss A, Aumayr K, Hackl M, Heber S, Chambers DJ, Hallström S, Podesser BK. St Thomas’ Hospital polarizing blood cardioplegia improves hemodynamic recovery in a porcine model of cardiopulmonary bypass. JThorac Cardiovasc Surg. 2019;158:1543-1554.

Publications BIO:

  • Egger F, Hofer C, Hammerle FP, Löfler S, Nürnberg M, Fiedler L, Kriz R, Kern H, Huber K. Influence of electrical stimulation therapy on permanent pacemaker function. Wien Klin Wochenschr. 2019;131:313-320
  • Gruber SC, Freynhofer MK, Willheim M, Weiss TW, Egger F, Hübl W, Huber K. Twenty-four-hour time dependency of clopidogrel effects in patients with acute coronary syndromes: The CiCAD-Study. Platelets. 2019;30:506-512.
  • Haller PM, Stojkovic S, Piackova E, Andric T, Wisgrill L, Spittler A, Wojta J, Huber K, Jäger B. The association of P2Y12 inhibitors with pro- coagulatory extracellular vesicles and microRNAs in stable coronary artery disease. Platelets. 2020;31:497-504.
  • Jäger B, Piackova E, Haller PM, Andric T, Kahl B, Christ G, Geppert A, Wojta J, Huber K. Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy. Arch Med Sci. 2019;15:65-71.
  • Jäger B, Stojkovic S, Haller PM, Piackova E, Kahl BS, Andric T, Vargas KG, Wojta J, Huber K. Course of platelet miRNAs after cessation of P2Y12 antagonists. Eur J Clin Invest. 2019;49:e13149.
  • Kaufmann CC, Lyon AR, Wojta J, Huber K. Is P2Y12 inhibitor therapy associated with an increased risk of cancer? Eur Heart J Cardiovasc Pharmacother. 2019;5:100-104.
  • Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K; ESC Scientific Document Group. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace. 2019;21:192-193.
  • Stojkovic S, Nossent AY, Haller P, Jäger B, Vargas KG, Wojta J, Huber K. MicroRNAs as regulators and biomarkers of platelet function and activity in coronary artery disease. Thromb Haemost. 2019;119:1563-1572.
  • Tscharre M, Herman R, Rohla M, Piackova E, Vargas KG, Farhan S, Freynhofer MK, Weiss TW, Huber K. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention. J Clin Lipidol. 2019;13:115-122.
  • Vargas KG, Haller PM, Jäger B, Tscharre M, Binder RK, Mueller C, Lindahl B, Huber K. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis. Clin Res Cardiol. 2019;108:749-762.

Associated publications of the LBI for Cardiovascular Research 2019

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the institute and are listed below.

  • Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Emdin M. Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome. Eur J Prev Cardiol. 2019;26:1751-1759.
  • Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Rocca HB, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Wilson Tang WH, Grodin JL, Passino C, Emdin M. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. Int J Cardiol. 2019;277:166-172.
  • Åkerblom A, Wojdyla D, Steg PG, Wallentin L, James SK, Budaj A, Katus HA, Himmelmann A, Huber K, Siegbahn A, Storey RF, Becker RC; PLATO Investigators. Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. J Thromb Thrombolysis. 2019;48:563-569.
  • Aradi D, Gross L, Trenk D, Geisler T, Merkely B, Kiss RG, Komócsi A, Dézsi CA, Ruzsa Z, Ungi I, Rizas KD, May AE, Mügge A, Zeiher AM, Holdt L, Huber K, Neumann FJ, Koltowski L, Huczek Z, Hadamitzky M, Massberg S, Sibbing D. Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial. Eur Heart J. 2019;40:1942-1951.
  • Basic J, Stojkovic S, Assadian A, Rauscher S, Duschek N, Kaun C, Wojta J, Falkensammer J. The relevance of vascular endothelial growth factor, hypoxia inducible factor-1 alpha, and clusterin in carotid plaque instability. J Stroke Cerebrovasc Dis. 2019;28:1540-1545.
  • Beygui F, Castren M, Brunetti ND, Rosell-Ortiz F, Christ M, Zeymer U, Huber K, Folke F, Svensson L, Bueno H, Van’t Hof A, Nikolaou N, Nibbe L, Charpentier S, Swahn E, Tubaro M, Goldstein P; ACCA study group on pre-hospital care. Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC. Eur Heart J Acute Cardiovasc Care. 2020;9(1_suppl):59-81.
  • Capodanno D, Huber K, Mehran R, Lip GYH, Faxon DP, Granger CB, Vranckx P, Lopes RD, Montalescot G, Cannon CP, Ten Berg J, Gersh BJ, Bhatt DL, Angiolillo DJ. Management of antithrombotic therapy in atrial fibrillation patients undergoing PCI: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:83-99.
  • Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A. Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. Heart. 2019;105:235-242.
  • Citro A, Moser PT, Dugnani E, Rajab TK, Ren X, Evangelista-Leite D, Charest JM, Peloso A, Podesser BK, Manenti F, Pellegrini S, Piemonti L, Ott HC. Biofabrication of a vascularized islet organ for type 1 diabetes. Biomaterials. 2019;199:40-51.
  • Clifford R, Robson D, Gross C, Moscato F, Schima H, Jansz P, Macdonald PS, Hayward CS. Beat-to beat detection of aortic valve opening in HeartWare left ventricular assist device patients. Artif Organs. 2019;43:458-466.
  • Drexel H, Rosano GMC, Lewis BS, Huber K, Vonbank A, Dopheide JF, Mader A, Niessner A, Savarese G, Wassmann S, Agewall S. The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials. Eur Heart J Cardiovasc Pharmacother. 2020;6:97-103.
  • Eilenberg W, Stojkovic S, Kaider A, Piechota-Polanczyk A, Nanobachvili J, Domenig CM, Wojta J, Huk I, Demyanets S, Neumayer C. Neutrophil g elatinae associated lipocalin (NGAL) for identification of unstable plaques in patients with asymptomatic carotid stenosis. Eur J Vasc Endovasc Surg. 2019;57:768-777.
  • Fabris E, Van’t Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Kerneis M, Diallo A, Vicaut E, Montalescot G; ATLANTIC investigators. Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial. Catheter Cardiovasc Interv. 2019;93:E369-E377.
  • Fabris E, van ‘t Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Tsatsaris A, Kerneis M, Diallo A, Vicaut E, Montalescot G. Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial. Eur Heart J Acute Cardiovasc Care. 2019;8:208-217.
  • Feistritzer HJ, Desch S, Zeymer U, Fuernau G, de Waha-Thiele S, Dudek D, Huber K, Stepinska J, Schneider S, Ouarrak T, Thiele H. Prognostic impact of atrial fibrillation in acute myocardial infarction and cardiogenic shock. Circ Cardiovasc Interv. 2019;12:e007661.
  • Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg PG, Heg D, Jüni P, Windecker S, Valgimigli M; GLASSY Investigators. Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting. J Am Coll Cardiol. 2019;74:2223-2234.
  • Freynhofer MK, Hein-Rothweiler R, Haller PM, Aradi D, Dézsi DA, Gross L, Orban M, Trenk D, Geisler T, Huczek Z, Toth-Gayor GG, Massberg S, Huber K, Sibbing D. Diurnal variability of on-treatment platelet reactivity in clopidogrel versus prasugrel Ttreated acute coronary syndrome patients: A pre-specified TROPICAL-ACS sub-study. Thromb Haemost. 2019;119:660-667.
  • Giannitsis E, Clifford P, Slagman A, Ruedelstein R, Liebetrau C, Hamm C, Honnart D, Huber K, Vollert JO, Simonelli C, Schröder M, Wiemer JC, Mueller-Hennessen M, Schroer H, Kastner K, Möckel M. Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry. BMJ Open. 2019;9:e028311.
  • Geisler T, Jorbenadze R, Popov AF, Mueller KL, Rath D, Droppa M, Schreieck J, Seizer P, Storey RF, Kristensen SD, Rubboli A, Gorog D, Aradi D, Sibbing D, Huber K, Gawaz M, Ten Berg J. Thrombogenicity and antithrombotic strategies in structural heart interventions and nonaortic cardiac device therapy-current evidence and practice. Thromb Haemost. 2019;119:1590-1605.
  • Goldstein SA, Green J, Huber K, Wojdyla DM, Lopes RD, Alexander JH, Vinereanu D, Wallentin L, Granger CB, Al-Khatib SM. Characteristics and outcomes of atrial fibrillation in patients with thyroid disease (from the ARISTOTLE trial). Am J Cardiol. 2019;124:1406-1412.
  • Goncalves-Alves E, Saferding V, Schliehe C, Benson R, Kurowska-Stolarska M, Brunner JS, Puchner A, Podesser BK, Smolen JS, Redlich K, Bonelli M, Brewer J, Bergthaler A, Steiner G, Blüml S. MicroRNA-155 controls T helper cell activation during viral infection. Front Immunol. 2019;10:1367.
  • Gross L, Kupka D, Trenk D, Geisler T, Hadamitzky M, Löw A, Orban M, Huber K, Kiss RG, Merkely B, Huczek Z, Beuthner BE, Hein-Rothweiler R, Baylacher M, Rizas K, Massberg S, Aradi D, Sibbing D, Jacobshagen C. Gender and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: The TROPICAL-ACS gender substudy. Thromb Haemost. 2019;119:1527-1538.
  • Håkansson KEJ, Goossens EAC, Trompet S, van Ingen E, de Vries MR, van der Kwast RVCT, Ripa RS, Kastrup J, Hohensinner PJ, Kaun C, Wojta J, Böhringer S, Le Cessie S, Jukema JW, Quax PHA, Nossent AY. Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular disease. Cardiovasc Res. 2019;115:1519-1532.
  • Haller PM, Sulzgruber P, Kaufmann C, Geelhoed B, Tamargo J, Wassmann S, Schnabel RB, Westermann D, Huber K, Niessner A, Gremmel T. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2019;5:226-236.
  • Hayer S, Zeilinger M, Weiss V, Dumanic M, Seibt M, Niederreiter B, Shvets T, Pichler F, Wadsak W, Podesser BK, Helbich TH, Hacker M, Smolen JS, Redlich K, Mitterhauser M. Multimodal [18F]FDG PET/CT is a direct readout for inflammatory bone repair: A longitudinal study in TNFα transgenic mice. J Bone Miner Res. 2019;34:1632-1645.
  • Kaniusas E, Kampusch S, Tittgemeyer M, Panetsos F, Gines RF, Papa M, Kiss A, Podesser B, Cassara AM, Tanghe E, Samoudi AM, Tarnaud T, Joseph W, Marozas V, Lukosevicius A, Ištuk N, Lechner S, Klonowski W, Varoneckas G, Széles JC, Šarolić A. Current directions in the auricular vagus nerve stimulation II – an engineering Perspective. Front Neurosci. 2019;13:772.
  • Kaniusas E, Kampusch S, Tittgemeyer M, Panetsos F, Gines RF, Papa M, Kiss A, Podesser B, Cassara AM, Tanghe E, Samoudi AM, Tarnaud T, Joseph W, Marozas V, Lukosevicius A, Ištuk N, Šarolić A, Lechner S, Klonowski W, Varoneckas G, Széles JC. Current directions in the auricular vagus nerve stimulation I – a physiological perspective. Front Neurosci. 2019;13:854.
  • Kastl SP, Krychtiuk KA, Lenz M, Distelmaier K, Goliasch G, Huber K, Wojta J, Heinz G, Speidl WS. Intestinal fatty acid binding protein is associated with mortality in patients with acute heart failure or cardiogenic shock. Shock. 2019;51:410-415.
  • Koltowski L, Tomaniak M, Gross L, Rymuza B, Kowara M, Parma R, Komosa A, Klopotowski M, Jacobshagen C, Gori T, Aradi D, Huber K, Hadamitzky M, Massberg S, Lesiak M, Filipiak KJ, Witkowski A, Opolski G, Huczek Z, Sibbing D. Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial. J Thromb Thrombolysis. 2019;47:427-435.
  • Krychtiuk KA, Huber K, Leonardi S. Acute Cardiovascular Care 2019. Eur Heart J. 2019;40:1903-1906.
  • Lapostolle F, Van’t Hof AW, Hamm CW, Stibbe O, Ecollan P, Collet JP, Silvain J, Lassen JF, Heutz WMJM, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Ten Berg J, Zeymer U, Licour M, Tsatsaris A, Montalescot G; ATLANTIC Investigators. Morphine and ticagrelor interaction in primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: ATLANTIC-morphine. Am J Cardiovasc Drugs. 2019;19:173-183.
  • Leonardi S, Franzone A, Piccolo R, McFadden E, Vranckx P, Serruys P, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg G, Heg D, Juni P, Windecker S, Valgimigli M. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY). BMJ Open. 2019;9:e026053.
  • Leutner M, Tscharre M, Farhan S, Taghizadeh Waghefi H, Harreiter J, Vogel B, Tentzeris I, Szekeres T, Fritzer-Szekeres M, Huber K, Kautzky-Willer A. A Sex- Specific analysis of the predictive value of troponin I and T in patients with and without diabetes mellitus after successful coronary intervention. Front Endocrinol. 2019;10:105.
  • Nossent AY, Ektefaie N, Wojta J, Eichelberger B, Kopp C, Panzer S, Gremmel T. Plasma levels of snoRNAs are associated with platelet activation in patients with peripheral artery disease. Int J Mol Sci. 2019;20:5975.
  • Orban M, Trenk D, Geisler T, Rieber J, Hadamitzky M, Gross L, Orban M, Kupka D, Baylacher M, Müller S, Huber K, Koltowski L, Huczek Z, Heyn J, Jacobshagen C, Aradi D, Massberg S, Sibbing D, Hein R; TROPICAL-ACS Investigators. Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: A substudy from the randomized TROPICAL-ACS trial. Eur Heart J Cardiovasc Pharmacother. 2019:pvz084.
  • O’Donoghue ML, Fazio S, Giugliano RP, Stroes ESG, Kanevsky E, Gouni-Berthold I, Im K, Lira Pineda A, Wasserman SM, Češka R, Ezhov MV, Jukema JW, Jensen HK, Tokgözoğlu SL, Mach F, Huber K, Sever PS, Keech AC, Pedersen TR, Sabatine MS. Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk. Circulation. 2019;139:1483-1492.
  • Osmanagic-Myers S, Kiss A, Manakanatas C, Hamza O, Sedlmayer F, Szabo PL, Fischer I, Fichtinger P, Podesser BK, Eriksson M, Foisner R. Endothelial progerin expression causes cardiovascular pathology through an impaired mechanoresponse. J Clin Invest. 2019;129:531-545.
  • Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Ricci F, Kirchhof P, De Caterina R. Net clinical benefit of non-vitamin K antagonist vs vitamin K antagonist anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2019;132:749-757.
  • Puhm F, Afonyushkin T, Resch U, Obermayer G, Rohde M, Penz T, Schuster M, Wagner G, Rendeiro AF, Melki I, Kaun C, Wojta J, Bock C, Jilma B, Mackman N, Boilard E, Binder CJ. Mitochondria are a subset of extracellular vesicles released by activated monocytes and induce type I IFN and TNF responses in endothelial cells. Circ Res. 2019;125:43-52.
  • Richter B, Sulzgruber P, Koller L, Steininger M, El-Hamid F, Rothgerber DJ, Forster S, Goliasch G, Silbert BI, Meyer EL, Hengstenberg C, Wojta J, Niessner A. Blood urea nitrogen has additive value beyond estimated glomerular filtration rate for prediction of long-term mortality in patients with acute myocardial infarction. Eur J Intern Med. 2019;59:84-90.
  • Richter B, Uray T, Krychtiuk KA, Schriefl C, Lenz M, Nürnberger A, Kastl SP, Wojta J, Heinz G, Schwameis M, Speidl WS. Growth differentiation factor-15 predicts poor survival after cardiac arrest. Resuscitation. 2019;143:22-28.
  • Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events – European Registry in Atrial Fibrillation (PREFER in AF).BMJ Open. 2019;9:e022478.
  • Tillmann K, Windschnurer I, Gamper J, Hinney B, Rülicke T, Podesser BK, Troxler J, Plasenzotti R. Welfare assessment in rabbits raised for meat and laboratory purposes in enclosures with two floor types: Perforated plastic with holes versus slats. Res Vet Sci. 2019;122:200-209.
  • Tscharre M, Farhan S, Bruno V, Rohla M, Egger F, Weiss TW, Hübl W, Willheim M, Wojta J, Geppert A, Huber K, Freynhofer MK. Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention. Eur J Clin Invest. 2019;49:e13157.
  • Tscharre M, Vogel B, Tentzeris I, Freynhofer MK, Rohla M, Wojta J, Weiss TW, Ay C, Huber K, Farhan S. Prognostic impact of soluble P-selectin on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention. Thromb Haemost. 2019;119:340-347.
  • Wadowski PP, Pultar J, Weikert C, Eichelberger B, Panzer B, Huber K, Lang IM, Koppensteiner R, Panzer S, Gremmel T. Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors. Res Pract Thromb Haemost. 2019;3:383-390.
  • Wadowski PP, Steinlechner B, Zimpfer D, Schlöglhofer T, Schima H, Hülsmann M, Lang IM, Gremmel T, Koppensteiner R, Zehetmayer S, Weikert C, Pultar J, Jilma B. Functional capillary impairment in patients with ventricular assist devices. Sci Rep. 2019;9:5909.
  • Wernly B, Mirna M, Rezar R, Prodinger C, Jung C, Podesser BK, Kiss A, Hoppe UC, Lichtenauer M. Regenerative cardiovascular therapies: Stem cells and beyond. Int J Mol Sci. 2019;20:1420.
  • Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention: Insights from the AUGUSTUS trial. Circulation. 2019;140:1921-1932.
  • Zagrapan B, Eilenberg W, Prausmueller S, Nawrozi P, Muench K, Hetzer S, Elleder V, Rajic R, Juster F, Martelanz L, Hayden H, Klopf J, Inan C, Teubenbacher P, Weigl MP, Kirchweger P, Beitzke D, Jilma B, Wojta J, Bailey MA, Scott DJA, Huk I, Neumayer C, Brostjan C. A novel diagnostic and prognostic score for abdominal aortic aneurysms based on D-dimer and a comprehensive analysis of myeloid cell parameters. Thromb Haemost. 2019;119:807-820.
  • Zlabinger K, Spannbauer A, Traxler D, Gugerell A, Lukovic D, Winkler J, Mester-Tonczar J, Podesser B, Gyöngyösi M. MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1+Sca-1+c-kit+ porcine cardiac progenitor cells in vitro. Cells. 2019;8:1416.

Publications of the LBI for Cardiovascular Research 2018

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered to be publications of the cluster.

Publications ASC:

  • Gross C, Marko C, Mikl J, Altenberger J, Schlöglhofer T, Schima H, Zimpfer D, Moscato F. LVAD pump flow does not adequately increase with exercise. Artif Organs. 2019;43:222-228. IF= 2,379
  • Schlöglhofer T, Horvat J, Moscato F, Hartner Z, Necid G, Schwingenschlögl H, Riebandt J, Dimitrov K, Angleitner P, Wiedemann D, Laufer G, Zimpfer D, Schima H. A standardized telephone intervention algorithm improves the survival of ventricular assist device outpatients. Artif Organs. 2018;42:961-969. IF 2.379

Publications INFO:

  • Hohensinner PJ, Baumgartner J, Ebenbauer B, Thaler B, Fischer MB, Huber K, Speidl WS, Wojta J. Statin treatment reduces matrix degradation capacity of proinflammatory polarized macrophages. Vascul Pharmacol. 2018;110:49-54. IF 3.330
  • Hohensinner PJ, Kaun C, Ebenbauer B, Hackl M, Demyanets S, Richter D, Prager M, Wojta J, Rega-Kaun G. Reduction of premature aging markers after gastric bypass surgery in morbidly obese patients. Obes Surg. 2018;28:2804-2810. IF 3.603
  • Krychtiuk KA, Stojkovic S, Lenz M, Brekalo M, Huber K, Wojta J, Heinz G, Demyanets S, Speidl WS. Predictive value of low interleukin-33 in critically ill patients. Cytokine. 2018;103:109-113. IF 3.078
  • Stojkovic S, Kaider A, Koller L, Brekalo M, Wojta J, Diedrich A, Demyanets S, Pezawas T. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2. J Cell Mol Med. 2018;22:2422-2429. IF 4.658
  • Wojta J, Guzik T, Pearson JD. Pushing the frontiers of cardiovascular biology. Cardiovasc Res. 2018;114(3):e22. IF 7.014

Publications REM:

  • Bergmeister KD, Aman M, Podesser BK. Restricted working hours in Austrian residency programs : Survey results. Wien Klin Wochenschr. 2018;130:404-407. IF 1.170
  • Kiss A, Podesser BK. Low-dose of relaxin protects against arrhythmias and adverse left ventricle remodeling. Int J Cardiol. 2018;250:60-61. IF 3.471
  • Kiss A, Shu H, Hamza O, Santer D, Tretter EV, Yao S, Markstaller K, Hallström S, Podesser BK, Klein KU. Argon preconditioning enhances postischaemic cardiac functional recovery following cardioplegic arrest and global cold ischaemia. Eur J Cardiothorac Surg. 2018;54:539-546. IF 3.847
  • Podesser BK, Kreibich M, Dzilic E, Santer D, Förster L, Trojanek S, Abraham D, Krššák M, Klein KU, Tretter EV, Kaun C, Wojta J, Kapeller B, Gonçalves IF, Trescher K, Kiss A. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis. J Hypertens. 2018;36:847-856. IF 4.209

Publications BIO:

  • Alber HF, Huber K. Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a review. Wien Klin Wochenschr. 2018;130:694-697. IF 1.170
  • Egger F, Zweiker D, Freynhofer MK, Löffler V, Rohla M, Geppert A, Farhan S, Vogel B, Falkensammer J, Kastner J, Pichler P, Vock P, Lamm G, Luha O, Schmidt A, Scherr D, Hammerer M, Hoppe UC, Maurer E, Grund M, Lambert T, Tkalec W, Sturmberger T, Zeindlhofer E, Grabenwöger M, Huber K; Austrian TAVI Group. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018 Nov 12;11(21):2160-2167. IF 9.544
  • Haller PM, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K, for the Vienna STEMI Registry Group. Impact of age on short- and long-term mortality of patients with ST-elevation myocardial infarction in the Vienna STEMI Network. Wien Klin Wochenschr. 2018;130:172-181. IF 1.170
  • Haller PM, Vargas KG, Haller MC, Piackova E, Wojta J, Gyöngyösi M, Gersh BJ, Kiss A, Podesser BK, Huber K. Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomized trials. Eur Heart J Acute Cardiovasc Care. 2018:2048872618784150. IF 3.734
  • Huber K. Current definitions of non-ST-segment elevation myocardial infarction: challenges for further improvement. JACC Cardiovasc Interv. 2018 May 14;11(9):865-867. IF 9.544
  • Huber K. Is Treatment of ST-segment-elevation myocardial infarction patients with ticagrelor or other P2Y(12) inhibitors before primary percutaneous coronary intervention a strategy without benefit? Circ Cardiovasc Interv. 2018;11:e006555. IF 6.060
  • Lip GYH, Collet JP, Haude M, Huber K. Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A Summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Eur Heart J. 2018;39:2847-2850. IF 23.239
  • Tajsic M, Járai R, Koch J, Stangl K, Wojta J, Dreger H, Huber K. Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome – The WilCop study. Int J Cardiol. 2018;273:243-248. IF 3.471
  • Tscharre M, Herman R, Rohla M, Hauser C, Farhan S, Freynhofer MK, Huber K, Weiss TW. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Atherosclerosis. 2018;270:173-179. IF 4.255

Publications ECP:

  • Schneider KH, Enayati M, Grasl C, Walter I, Budinsky L, Zebic G, Kaun C, Wagner A, Kratochwill K, Redl H, Teuschl AH, Podesser BK, Bergmeister H. Acellular vascular matrix grafts from human placenta chorion: Impact of ECM preservation on graft characteristics, protein composition and in vivo performance. Biomaterials. 2018;177:14-26. IF 10.273

Associated publications of the LBI for Cardiovascular Research 2018

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

  • Aimo A, Januzzi J, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand I, Cohn J, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo S, Brunner-LA Rocca H, Bayes-Genis A, Lupon J, de Boer R, Yoshihisa A, Yasuchika T, Egstrup M, Gustafsson I, Gaggin H, Eggers K, Huber K, Tentzeirs J, Tang WH, Grodin J, Passino C, Emdin M. Prognostic value of high-sensitivity troponin T in chronic heart failure. An individual patient data meta-analysis. Circulation. 2018;137:286-297. IF 23.054
  • Andreas M, Haberl T, Werner P, Guri J, Kocher A, Hamza O, Podesser B, Laufer G. Mitral valve repair with adjustable ring annuloplasty. Multimed Man Cardiothorac Surg. 2018;2018.
  • Bagai A, Goodman SG, Cantor WJ, Vicaut E, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Merkely B, Storey RF, Ten Berg JM, Zeymer U, Diallo A, Hamm CW, Tsatsaris A, El Khoury J, Van’t Hof AW, Montalescot G. Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study. Am Heart J. 2018;196:56-64. IF 4.023
  • Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Angelini GD, Flather M, Taggart DP; ART (Arterial Revascularization Trial) Investigators. Safety of perioperative aprotinin administration during isolated coronary artery bypass graft surgery: Insights from the ART (Arterial Revascularization Trial). J Am Heart Assoc. 2018;7. pii: e007570. IF 4.660
  • Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Flather M, Taggart DP; Arterial Revascularization Trial investigators. Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial. J Thorac Cardiovasc Surg. 2018 155:1545-1553. IF 5.261
  • Bonelli M, Puchner A, Göschl L, Hayer S, Niederreiter B, Steiner G, Tillmann K, Plasenzotti R, Podesser B, Georgel P, Smolen J, Scheinecker C, Blüml S. CCR6 controls autoimmune but not innate immunity-driven experimental arthritis. J Cell Mol Med. 2018;22:5278-5285. IF 4.658
  • Dew MA, DiMartini AF, Dobbels F, Grady KL, Jowsey-Gregoire SG, Kaan A, Kendall K, Young QR, Abbey SE, Butt Z, Crone CC, De Geest S, Doligalski CT, Kugler C, McDonald L, Ohler L, Painter L, Petty MG, Robson D, Schlöglhofer T, Schneekloth TD, Singer JP, Smith PJ, Spaderna H, Teuteberg JJ, Yusen RD, Zimbrean PC. The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support. Psychosomatics. 2018;59:415-440. IF 1.541
  • Collet JP, Kerneis M, Lattuca B, Yan Y, Cayla G, Silvain J, Lapostolle F, Ecollan P, Diallo A, Vicaut E, Hamm CW, Van ‘t Hof AW, Montalescot G; ATLANTIC Investigators. Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis. EuroIntervention. 2018;14:789-797. IF 4.018
  • Dew MA, DiMartini AF, Dobbels F, Grady KL, Jowsey-Gregoire SG, Kaan A, Kendall K, Young QR, Abbey SE, Butt Z, Crone CC, De Geest S, Doligalski CT, Kugler C, McDonald L, Ohler L, Painter L, Petty MG, Robson D, Schlöglhofer T, Schneekloth TD, Singer JP, Smith PJ, Spaderna H, Teuteberg JJ, Yusen RD, Zimbrean PC. The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. J Heart Lung Transplant. 2018;37:803-823. IF 8.578
  • Djinović Z, Pavelka R, Tomić M, Sprinzl G, Plenk H, Losert U, Bergmeister H, Plasenzotti R. In-vitro and in-vivo measurement of the animal’s middle ear acoustical response by partially implantable fiber-optic sensing system. Biosens Bioelectron. 2018;103:176-181. IF 9.518
  • Goto S, Merrill P, Wallentin L, Wojdyla DM, Hanna M, Avezum A, Easton JD, Harjola VP, Huber K, Lewis BS, Parkhomenko A, Zhu J, Granger CB, Lopes RD, Alexander JH. Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE. Eur Heart J Cardiovasc Pharmacother. 2018;4:75-81. IF 6.723
  • Hinohara TT, Roe MT, White HD, Fox KAA, Bhatt DL, Hamm C, Gurbel PA, Aylward PE, Wiviott SD, Huber K, Neely ML, Ohman EM. Outcomes of patients receiving downstream revascularization after initial medical management for non-ST-segment elevation acute coronary syndromes (from the TRILOGY ACS trial). Am J Cardiol. 2018;122:1322-1329. IF 2.843
  • Kieler M, Unseld M, Wojta J, Kaider A, Bianconi D, Demyanets S, Prager GW. Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy. Med Oncol. 2018;36:1. IF 4.658
  • Königshofer P, Brusilovskaya K, Schwabl P, Podesser BK, Trauner M, Reiberger T. Invasive hemodynamic characterization of the portal-hypertensive syndrome in cirrhotic rats. J Vis Exp. 2018;(138) IF 1.108
  • Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. Am Heart J. 2018;197:133-141. IF 4.023
  • Mair J, Lindahl B, Hammarsten O, Müller C, Giannitsis E, Huber K, Möckel M, Plebani M, Thygesen K, Jaffe AS. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7:553-560. IF 3.734
  • Mair J, Lindahl B, Müller C, Giannitsis E, Huber K, Möckel M, Plebani M, Thygesen K, Jaffe AS. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care. 2018;7:577-586. IF 3.734
  • Marschalek J, Wohlrab P, Ott J, Wojta J, Speidl W, Klein KU, Kiss H, Pateisky P, Zeisler H, Kuessel L. Maternal serum mitochondrial DNA (mtDNA) levels are elevated in preeclampsia – A matched case-control study. Pregnancy Hypertens. 2018;14:195-199. IF 3.252
  • Moayedifar R, Zuckermann A, Aliabadi-Zuckermann A, Riebandt J, Angleitner P, Dimitrov K, Schloeglhofer T, Rajek A, Laufer G, Zimpfer D. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg. 2018;54:1116-1121.
  • Mueller C, Möckel M, Giannitsis E, Huber K, Mair J, Plebani M, Thygesen K, Jaffe AS, Lindahl B; ESC Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association. Use of copeptin for rapid rule-out of acut myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2018;7:570-576. IF 3.734
  • Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Schnabel RB, Cemin R, Kirchhof P, De Caterina R. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy – A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. Int J Cardiol. 2018;270:160-166. IF 3.471
  • Pentz R, Kaun C, Thaler B, Stojkovic S, Lenz M, Krychtiuk KA, Zuckermann A, Huber K, Wojta J, Hohensinner PJ, Demyanets S. Cardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissue. J Cell Mol Med. 2018 22:6122-6133. IF 4.658
  • Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z. Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with oral anticoagulation therapy: insights from the ARISTOTLE (Apixaban for Reduction In STroke and Other ThromboemboLic Events in atrial fibrillation) trial. J Am Heart Assoc. 2018;7. pii: e007444. IF 4.660
  • Puchner A, Saferding V, Bonelli M, Mikami Y, Hofmann M, Brunner JS, Caldera M, Goncalves-Alves E, Binder NB, Fischer A, Simader E, Steiner CW, Leiss H, Hayer S, Niederreiter B, Karonitsch T, Koenders MI, Podesser BK, O’Shea JJ, Menche J, Smolen JS, Redlich K, Blüml S. Non-classical monocytes as mediators of tissue destruction in arthritis. Ann Rheum Dis. 2018;77:1490-1497. IF 14.299
  • Qi H, Soto-Gonzalez L, Krychtiuk KA, Ruhittel S, Kaun C, Speidl WS, Kiss A, Podesser BK, Yao S, Markstaller K, Klein KU, Tretter V. Pretreatment with argon protects human cardiac myocyte-like progenitor cells from oxygen glucose deprivation-induced cell death by activation of AKT and differential regulation of mapkinases. Shock. 2018;49:556-563. IF 3.083
  • Richter B, Sulzgruber P, Koller L, Steininger M, El-Hamid F, Rothgerber DJ, Forster S, Goliasch G, Silbert BI, Meyer EL, Hengstenberg C, Wojta J, Niessner A. Blood urea nitrogen has additive value beyond estimated glomerular filtration rate for prediction of long-term mortality in patients with acute myocardial infarction. Eur J Intern Med. 2019;59:84-90. IF 3.660
  • Riebandt J, Haberl T, Wiedemann D, Moayedifar R, Schloeglhofer T, Mahr S, Dimitrov K, Angleitner P, Laufer G, Zimpfer D. Extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg. 2018;53:590-595.
  • Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis. Eur Heart J. 2018;39:1672-1686. IF 23.239
  • Rohla M, Tscharre M, Huber K, Weiss TW. Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial. Wien Klin Wochenschr. 2018;130:698-706. IF 1.170
  • Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events – European Registry in Atrial Fibrillation (PREFER in AF). BMJ Open. 2019;9:e022478. IF 2.376
  • Sabatine MS, De Ferrari GM, Giugliano RP, Huber K, Lewis BS, Ferreira J, Kuder JF, Murphy SA, Wiviott SD, Kurtz CE, Honarpour N, Keech AC, Sever PS, Pedersen TR. Clinical benefit of evolocumab by severity and extent of coronary artery disease. Circulation. 2018;138:756-766. IF 23.054
  • Schettle S, Schlöglhofer T, Zimpfer D, Schima H, Kaufmann F, Salimbangon A, Wolforth J, Schroeder S, Hards R, Ritchie B, Staley L, Pereira N, Kushwaha S, Maltais S, Stulak J. International analysis of LVAD point-of-care versus plasma INR: A multicenter study. ASAIO J. 2018;64:e161-e165. IF 2.494
  • Schoergenhofer C, Schwameis M, Gelbenegger G, Buchtele N, Thaler B, Mussbacher M, Schabbauer G, Wojta J, Jilma-Stohlawetz P, Jilma B. Inhibition of protease-activated receptor (PAR1) reduces activation of the endothelium, coagulation, fibrinolysis and inflammation during human endotoxemia. Thromb Haemost. 2018;118:1176-1184. IF 4.733
  • Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T. The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats. Sci Rep. 2018;8:9372. IF 4.011
  • Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379:2097-2107. IF 70.670
  • Seidler K, Ehrmann K, Steinbauer P, Rohatschek A, Andriotis OG, Dworak C, Koch T, Bergmeister H, Grasl C, Schima H, Thurner P J, Liska R, Baudis S. A structural reconsideration: Linear aliphatic or alicyclic hard segments for biodegradable thermoplastic polyurethanes? J Polym Sci Part A Polym Chem. 2018;56:2214-2224.
  • Sibbing D, Gross L, Trenk D, Jacobshagen C, Geisler T, Hadamitzky M, Merkely B, Kiss RG, Komócsi A, Parma R, Felix SB, Neumann FJ, Hausleiter J, Baylacher M, Koltowski L, Mehilli J, Huber K, Huczek Z, Aradi D, Massberg S; TROPICAL-ACS Investigators. Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial. Eur Heart J. 2018;39:2749-2758. IF 23.239
  • Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R; TEAM in AF group. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF – HF substudy. Int J Cardiol. 2018;265:141-147. IF 3.471
  • Steininger M, Winter MP, Reiberger T, Koller L, El-Hamid F, Forster S, Schnaubelt S, Hengstenberg C, Distelmaier K, Goliasch G, Wojta J, Toma A, Niessner A, Sulzgruber P. De-Ritis ratio improves long-term risk prediction after acute myocardial infarction. J Clin Med. 2018;7. pii: E474. IF 5.688
  • Stojkovic S, Jurisic M, Kopp CW, Koppensteiner R, Huber K, Wojta J, Gremmel T. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation. Atherosclerosis. 2018;269:197-203. IF 4.255
  • Sulzgruber P, Thaler B, Koller L, Baumgartner J, Pilz A, Steininger M, Schnaubelt S, Fleck T, Laufer G, Steinlechner B, Winter MP, Goliasch G, Wojta J, Niessner A. CD4(+)CD28(null) T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery. Sci Rep. 2018;8:9624. IF 4.011
  • Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S; CULPRIT-SHOCK Investigators. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379:1699-1710. IF 70.670
  • Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK; GARFIELD-AF Investigators. Characteristic patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry. Eur Heart J. 2018;39:464-473. IF 23.239
  • Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S; GLOBAL LEADERS Investigators. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018;392:940-949. IF 59.102
  • Wiedemann D, Schlöglhofer T, Haberl T, Riebandt J, Dimitrov K, Schima H, Kastner J, Matzek W, Laufer G, Zimpfer D. Interventional treatment of LVAD outflow graft stenosis by introduction of bare metal stents. ASAIO J. 2018;64:e3-e7. IF 2.494
  • Winter MP, Wiesbauer F, Blessberger H, Pavo N, Sulzgruber P, Huber K, Wojta J, Distelmaier K, Lang IM, Goliasch G. Lipid profile and long-term outcome in premature myocardial infarction. Eur J Clin Invest. 2018;48:e13008. IF 2.748
  • Young C, Laufer G, Kocher A, Solinas M, Alamanni F, Polvani G, Podesser BK, Aramendi JI, Arribas J, Bouchot O, Livi U, Massetti M, Terp K, Giot C, Glauber M. One-year outcomes after rapid-deployment aortic valve replacement. J Thorac Cardiovasc Surg. 2018;155:575-585. IF 5.261
  • Zlabinger K, Lukovic D, Hemetsberger R, Gugerell A, Winkler J, Mandic L, Traxler D, Spannbauer A, Wolbank S, Zanoni G, Kaun C, Posa A, Gyenes A, Petrasi Z, Petnehazy Ö, Repa I, Hofer-Warbinek R, de Martin R, Gruber F, Charwat S, Huber K, Pavo N, Pavo IJ, Nyolczas N, Kraitchman DL, Gyöngyösi M. Matrix metalloproteinase-2 impairs homing of intracoronary delivered mesenchymal stem cells in a porcine reperfused myocardial infarction: comparison with intramyocardial cell delivery. Front Bioeng Biotechnol. 2018;6:35. IF 5.122